Skip to main content

Table 2 Baseline data profile by diet group

From: Effect of dietary patterns differing in carbohydrate and fat content on blood lipidand glucose profiles based on weight-loss success of breast-cancer survivors

Variable Control
(n= 44)
Low fat
(n= 50)
Low carb
(n= 48)
P
(Global Ftest)
Age (years) 56.61 ± 7.73 56.32 ± 8.08 55.19 ± 8.09 0.66
BMI 29.13 ± 2.92 28.37 ± 2.43 29.47 ± 2.65 0.12
Weight (lb) 175.53 ± 22.25 172.11 ± 18.54 176.74 ± 20.17 0.51
% Fat mass 43.37 ± 5.63 42.31 ± 4.91 43.65 ± 4.86 0.39
Glucose 83.60 ± 8.46 83.40 ± 9.22 86.33 ± 6.87 0.16
Cholesterol 204.72 ± 31.55 204.08 ± 42.41 201.66 ± 31.92 0.91
Triglycerides 133.28 ± 53.96 113.54 ± 58.72 139.13 ± 69.48 0.10
HDL 59.49 ± 16.10 66.30 ± 18.56 61.28 ± 15.87 0.13
LDL 118.53 ± 29.76 115.12 ± 37.56 112.57 ± 28.99 0.69
Chol/HDL ratio 3.63 ± 0.97 3.28 ± 1.05 3.50 ± 1.08 0.25
Years since diagnosis 5.43 ± 4.09 6.78 ± 6.21 8.40 ± 5.80 0.037
Stage 0 (%) 9.1 12.0 4.2 0.38
Stage I (%) 38.6 34.0 43.8 0.62
Stage IIA (%) 22.7 28.0 27.1 0.73
Stage IIB (%) 15.9 18.0 10.4 0.56
Stage IIIA (%) 9.1 4.0 6.3 0.61
Stage IIIB (%) 4.5 4.0 4.2 0.33
Stage IIIC (%) 0.0 0.0 2.1 0.41
Chemotherapy (%) 56.8 70.0 62.5 0.41
Hormonal therapy (%) 77.3 82.0 77.1 0.80
Statins (%) 15.9 18.0 20.8 0.83
Other cholesterol-lowering
agents (%)
2.3 2.0 2.1 0.33
  1. Carb, carbohydrate; HDL, high-density lipoprotein; LDL, low-density lipoprotein.Values are expressed as mean ± standard deviation.